Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Out-of-Hospital Cardiac Arrest | 15 | 2019 | 1047 | 2.87 | Why? |
| Cardiopulmonary Resuscitation | 18 | 2021 | 1876 | 2.29 | Why? |
| Heart Arrest | 8 | 2021 | 1239 | 1.01 | Why? |
| Emergency Medical Dispatch | 1 | 2018 | 44 | 0.71 | Why? |
| Echocardiography, Transesophageal | 1 | 2019 | 447 | 0.58 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.45 | Why? |
| Defibrillators | 4 | 2019 | 144 | 0.44 | Why? |
| Virtual Reality | 1 | 2019 | 640 | 0.42 | Why? |
| Health Education | 2 | 2018 | 1539 | 0.38 | Why? |
| Emergency Medical Services | 4 | 2018 | 3557 | 0.34 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.33 | Why? |
| Point-of-Care Systems | 1 | 2019 | 2955 | 0.29 | Why? |
| Coma | 2 | 2017 | 204 | 0.29 | Why? |
| Oxygen | 1 | 2018 | 3715 | 0.27 | Why? |
| Healthcare Disparities | 4 | 2018 | 3893 | 0.27 | Why? |
| Hypothermia, Induced | 4 | 2019 | 176 | 0.25 | Why? |
| Emergency Service, Hospital | 4 | 2021 | 14232 | 0.24 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.24 | Why? |
| Pennsylvania | 2 | 2021 | 558 | 0.22 | Why? |
| Medical Futility | 1 | 2021 | 150 | 0.21 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.20 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.20 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.19 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.18 | Why? |
| Electric Countershock | 2 | 2017 | 284 | 0.18 | Why? |
| Emergency Medical Service Communication Systems | 1 | 2018 | 48 | 0.17 | Why? |
| Cytochromes c | 1 | 2017 | 44 | 0.17 | Why? |
| Manikins | 1 | 2019 | 466 | 0.15 | Why? |
| Arrhythmias, Cardiac | 2 | 2020 | 2510 | 0.15 | Why? |
| DNA, Mitochondrial | 1 | 2017 | 163 | 0.15 | Why? |
| Hospitals, Urban | 1 | 2021 | 950 | 0.15 | Why? |
| International Classification of Diseases | 1 | 2018 | 265 | 0.14 | Why? |
| Educational Status | 2 | 2018 | 1451 | 0.13 | Why? |
| Education | 1 | 2018 | 434 | 0.12 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.12 | Why? |
| Health Knowledge, Attitudes, Practice | 4 | 2019 | 8811 | 0.12 | Why? |
| Coronary Angiography | 2 | 2019 | 2275 | 0.12 | Why? |
| Odds Ratio | 3 | 2021 | 5861 | 0.11 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.11 | Why? |
| Transportation of Patients | 1 | 2017 | 494 | 0.11 | Why? |
| Lactic Acid | 1 | 2014 | 393 | 0.11 | Why? |
| Humans | 31 | 2021 | 930598 | 0.10 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.10 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.10 | Why? |
| Telephone | 1 | 2018 | 1705 | 0.09 | Why? |
| Female | 18 | 2021 | 380317 | 0.09 | Why? |
| Time Factors | 7 | 2019 | 31397 | 0.09 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.09 | Why? |
| Adult | 10 | 2021 | 244371 | 0.09 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.09 | Why? |
| Income | 1 | 2017 | 1564 | 0.09 | Why? |
| Registries | 5 | 2019 | 12327 | 0.08 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.08 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.08 | Why? |
| Illinois | 1 | 2007 | 468 | 0.07 | Why? |
| Delivery of Health Care, Integrated | 1 | 2017 | 1549 | 0.07 | Why? |
| Male | 15 | 2021 | 367725 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.07 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.07 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Norway | 1 | 2007 | 1004 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
| Austria | 1 | 2007 | 1259 | 0.06 | Why? |
| United States | 6 | 2021 | 46150 | 0.06 | Why? |
| Nucleic Acid Probes | 1 | 2021 | 38 | 0.06 | Why? |
| Patient Discharge | 4 | 2019 | 5696 | 0.06 | Why? |
| Hospital Mortality | 7 | 2020 | 22087 | 0.06 | Why? |
| Combined Modality Therapy | 2 | 2021 | 3395 | 0.05 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.05 | Why? |
| Antipyretics | 1 | 2020 | 107 | 0.05 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.05 | Why? |
| Brain Damage, Chronic | 1 | 2019 | 15 | 0.05 | Why? |
| Glucose Metabolism Disorders | 1 | 2019 | 22 | 0.05 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.05 | Why? |
| Risk Assessment | 3 | 2018 | 25439 | 0.05 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.05 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.05 | Why? |
| Hypoxia-Ischemia, Brain | 1 | 2019 | 86 | 0.05 | Why? |
| Grounded Theory | 1 | 2018 | 48 | 0.05 | Why? |
| Neuromuscular Blocking Agents | 1 | 2019 | 121 | 0.04 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.04 | Why? |
| Evoked Potentials, Somatosensory | 1 | 2017 | 40 | 0.04 | Why? |
| Reperfusion Injury | 1 | 2019 | 178 | 0.04 | Why? |
| Ribonuclease P | 1 | 2017 | 84 | 0.04 | Why? |
| Congresses as Topic | 1 | 2007 | 1347 | 0.04 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.04 | Why? |
| Adrenal Insufficiency | 1 | 2019 | 190 | 0.04 | Why? |
| Social Media | 1 | 2018 | 5798 | 0.04 | Why? |
| Treatment Outcome | 5 | 2018 | 51732 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.04 | Why? |
| Philadelphia | 1 | 2017 | 454 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.04 | Why? |
| Body Temperature | 1 | 2020 | 875 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| North Carolina | 1 | 2017 | 571 | 0.04 | Why? |
| Survivors | 2 | 2017 | 2619 | 0.03 | Why? |
| Fluid Therapy | 1 | 2019 | 628 | 0.03 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Anticonvulsants | 1 | 2019 | 634 | 0.03 | Why? |
| Patient Participation | 1 | 2021 | 829 | 0.03 | Why? |
| Hypnotics and Sedatives | 1 | 2019 | 624 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Reference Standards | 1 | 2017 | 1163 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2019 | 918 | 0.03 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Withholding Treatment | 1 | 2017 | 798 | 0.03 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.03 | Why? |
| Cardiomyopathies | 1 | 2019 | 997 | 0.02 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.02 | Why? |
| Program Evaluation | 1 | 2017 | 1929 | 0.02 | Why? |
| Multiple Organ Failure | 1 | 2019 | 1724 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2019 | 1956 | 0.02 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.02 | Why? |
| Urban Population | 1 | 2017 | 2000 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2019 | 3629 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.02 | Why? |
| African Americans | 1 | 2018 | 3363 | 0.02 | Why? |
| Information Dissemination | 1 | 2018 | 2986 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2017 | 5883 | 0.01 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2019 | 5762 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Biomarkers | 1 | 2014 | 23361 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
Abella's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(202)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_